Gamida Cell Ltd.

210 articles about Gamida Cell Ltd.

• Gamida Cell Ltd. and Cellerix Partner on Feasibility Study Pre-clinical Study Will Test new Method of Improving Clinical Efficacy of Expanded Populations of Adult Stem Cells Obtained From Adipose Tissue

  10/21/2009

• Gamida Cell Ltd. Release: Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma

  10/19/2009

• Gamida Cell Ltd.: Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma

  9/30/2009

• Gamida Cell Ltd. Release: StemEx(R), a Gamida Cell-TEVA Joint Venture Cell Therapy Product, Receives Orphan Medicinal Product Designation in the European Union

  3/11/2009

• Gamida Cell Ltd. Announces License Agreement with Amgen (JOBS) to Support Development and Commercialization of StemEx(R) for Hematological Malignancies

  7/21/2008

• Gamida Cell Ltd. Signs Collaboration Agreement With Biologics Delivery Systems Group

  7/14/2008

• NovaThera and Gamida Cell Ltd. Announce a Collaboration Agreement to Develop Cell Therapeutics for Lung Disease

  5/9/2007

• Gamida Cell Ltd.'s StemEx(R) Registration Study Receives Special Protocol Assessment From The FDA

  11/2/2006

• Gamida Cell Ltd. Raises US$16 Million

  9/27/2006

• Gamida Cell Ltd. Announces New Supporting Evidence That An Ex-Vivo Expanded Population Of Human Bone Marrow Stem Cells May Help Treat Heart Disease

  1/12/2006